LEIGHA CROWELL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health BALTIMORE, MD NPI 1033859152
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health MD Abbott Laboratories All categories
General Payments — all program years on this page
$2,020.15
- Category: General Payments
- Program years: PY2022–2024
- Record count: 58
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $422.72 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $422.72 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $202.75 | 4 |
| Fresenius Kabi USA, LLC | $140.85 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $30.21 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $24.95 | 1 |
| Amgen Inc. | $23.96 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086326452 | Bayer Healthcare Pharmaceuticals Inc. | $30.21 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086769475 | Novartis Pharmaceuticals Corporation | $24.95 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117231309 | Amgen Inc. | $23.96 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124808499 | Abbott Laboratories | $20.17 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124808501 | Abbott Laboratories | $21.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124808503 | Abbott Laboratories | $147.34 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124808505 | Abbott Laboratories | $14.19 | 12/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146955228 | Fresenius Kabi USA, LLC | $140.85 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.